| Combination of | |
|---|---|
| Estradiol | Estrogen | 
| Norethisterone acetate | Progestogen | 
| Clinical data | |
| Trade names | Activella, Amabelz, CombiPatch, others | 
| AHFS/Drugs.com | Professional Drug Facts | 
| MedlinePlus | a601041 | 
| Routes of administration | By mouth | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| CAS Number | |
| ChemSpider | 
 | 
|  N  Y (what is this?)  (verify) | |
Estradiol/norethisterone acetate (E2/NETA), sold under the brand name Activella among others, is a combination of estradiol (E2) and norethisterone acetate (NETA) which is used in the treatment of vasomotor symptoms, vulvar and vaginal atrophy, and osteoporosis[1] associated with menopause.[2] Activella specifically is marketed by Novo Nordisk and is supplied as film-coated tablets containing 1 mg estradiol and 0.5 mg norethisterone acetate. CombiPatch is a combination of estradiol and NETA provided as a transdermal patch.[2]
See also
References
- ↑ Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, et al. (October 2002). "Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study". Journal of Bone and Mineral Research. 17 (10): 1904–12. doi:10.1359/jbmr.2002.17.10.1904. PMID 12369794. S2CID 29312298.
- 1 2 "CombiPatch (estradiol/norethindrone acetate transdermal system) Prescribing Information" (PDF). Noven Pharmaceuticals, Inc. U.S. Food and Drug Administration.
| Progestogens (and progestins) | 
 | ||||
|---|---|---|---|---|---|
| Antiprogestogens | 
 | ||||
| 
 
 | |||||
| ERTooltip Estrogen receptor | 
 | ||||||
|---|---|---|---|---|---|---|---|
| GPERTooltip G protein-coupled estrogen receptor | 
 | ||||||
| 
 | |||||||
| PRTooltip Progesterone receptor | 
 | ||||||
|---|---|---|---|---|---|---|---|
| mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) | 
 | ||||||
| 
 | |||||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.